v3.25.1
Consolidated Statement of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenue $ 63,777 $ 498,917
Cost of goods sold 6,650,979 5,133,996
Gross loss (6,587,202) (4,635,079)
Operating expenses:    
Research and development 1,493,202 7,418,026
Sales and marketing 990,471 1,721,191
General and administrative 8,646,301 14,382,132
Loss on impairment of long-lived assets 1,659,835
Total operating expenses 12,789,809 23,521,349
Loss from operations (19,377,011) (28,156,428)
Other income (expense):    
Interest income 484,325 441,443
Change in fair value - warrant liability 10,956,900 (3,350,320)
Change in fair value - derivative liability 6,739,000 (4,253,000)
Unrealized gain (loss) on marketable securities (98,315) 215,900
Realized gain on marketable securities 1,322,971 941,950
Legal settlement (1,096,222)
Vendor settlement (647,833)
Other income (expense), net (39,294)
Total other income (expense), net 17,621,532 (6,004,027)
Net loss prior to provision for income taxes (1,755,479) (34,160,455)
Provision for income taxes
Net loss (1,755,479) (34,160,455)
Dividends earned on Series H-7 convertible preferred stock (2,425,599) (697,991)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock (8,255,150) (3,980,274)
Deemed dividend (Series H-5 warrants) (199,000)
Net loss attributable to common stockholders $ (12,436,228) $ (39,037,720)
Net loss per share basic $ (2.02) $ (8.19)
Net loss per share diluted $ (2.02) $ (8.19)
Basic weighted average Common Stock outstanding 6,170,439 4,764,494
Diluted weighted average Common Stock outstanding 6,170,439 4,764,494

Source